Galactooligosaccharides and substrate and energy metabolism, dietary intake and body composition

  • M.A.J. Dijck, van

Abstract

Aim: Obesity is associated with an altered composition of the gut microbiota. Prebiotics such as galactooligosaccharides (GOS) might modulate the gut microbiota composition beneficially and might have favorable metabolic effects in overweight and obese subjects. The aim of the study is to determine the effect of GOS on human substrate and energy metabolism, dietary intake and body composition in overweight and obese subjects. Methods: In a placebo-controlled, double-blind, randomized, parallel study, the effects of GOS were investigated in overweight and obese subjects. Weight-stable men and post-menopausal women between 40 and 75 years were included. Before and after the 12-week intervention period human substrate and energy expenditure were measured by indirect calorimetry. Subjects reported their dietary intake before, in week 6 and after the intervention period by completing a three-day weighed food diary. Self-reported level of physical activity was assessed using the validated SQUASH questionnaire. Changes in body composition were measured using a Dual-energy X-ray absorptiometry (DEXA) scan. A two-factor mixed analysis of variance (ANOVA) was performed to compare the intervention and placebo group. All analyses were performed blinded. Results: This interim analysis was performed after the data of 25 subjects was available. The data was blinded while analyzing. To maintain confidentiality of the data, the results of this interim analysis were not published. Conclusion: Only a part of the whole subject population was included in this interim analysis. The analyses in the total study group are required to draw more definite conclusions on the metabolic effects of GOS and to outline the potential of GOS to favorably affect host metabolism of overweight and obese subjects.

References

Bakel A, Zantinge E. Neemt het aantal mensen met overgewicht toe of af. Bilthoven: 2013.

Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-43.

Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10(6):729-34.

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-4.

Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-12.

Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. Dietary Gut Microbial Metabolites, Shortchain Fatty Acids, and Host Metabolic Regulation. Nutrients. 2015;7(4):2839-49.

Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104 Suppl 2:S1-63.

den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325-40.

Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013;143(3):324-31.

Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods. 2010(7):1-19.

Weir JBV. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109(1-2):1-9.

Overduin J, Schoterman MH, Calame W, Schonewille AJ, Ten Bruggencate SJ. Dietary galactooligosaccharides and calcium: effects on energy intake, fat-pad weight and satiety-related, gastrointestinal hormones in rats. Br J Nutr. 2013;109(7):1338-48.

Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2005;8(6):636-40.

van der Beek C, Canfora E, Lenaerts K, Troost F, Holst J, Masclee A, et al. OP038: Colonic Acetate Infusions Promote Fat Oxidation and Improve Metabolic Parameters in Overweight Males. Clinical Nutrition. 2014(33):S16-S7.

Corpeleijn E, Saris WH, Blaak EE. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev. 2009;10(2):178-93.

Torres DP, Gonçalves MdPF, Teixeira JA, Rodrigues LR. Galacto‐Oligosaccharides: Production, Properties, Applications, and Significance as Prebiotics. Compr Rev Food Sci Food Saf. 2010;9(5):438-54.

Published
2016-12-19